StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by polo11on Dec 03, 2016 12:32pm

102 Views

Post# 25550584

RE:RE:RE:RE:RE:how much will PP be ?

IS it you PBAY was expecting a pp well below .40 few weeks ago !!!

thepbay wrote: I guess you could spin it that way. Nobody looks at it that way thou. They lost 4 cents a share, worse then what I even thought. You also have to look at the loan that is due the month after these results, but who needs to look at that? If this board is thinking a PP at .40, you know it is going to be well below that number, at least now ppl are accepting that a PP is very much needed. 3000 test in a month, GL

pbay